WEDNESDAY, Dec. 15, 2021 (HealthDay News) — COVID-19 vaccination offers far much less safety to folks with a number of myeloma than to survivors of different kinds of most cancers, new analysis reveals.

The findings spotlight the necessity for a number of myeloma sufferers “to be especially careful — to take social distancing seriously and utilize masking — even if they’ve been vaccinated,” stated research senior writer Dr. Nikhil Munshi, from the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute in Boston.

The new findings come from a follow-up to analysis just lately printed in JAMA Oncology, the place COVID an infection charges had been assessed in practically 60,000 vaccinated and unvaccinated most cancers survivors who had not acquired a systemic most cancers therapy equivalent to chemotherapy or immunotherapy within the earlier six months.

The new research in contrast 818 adults with a number of myeloma who had been vaccinated towards COVID-19 with an equal variety of unvaccinated sufferers who additionally had the blood most cancers.

Also included had been practically 9,600 sufferers with a situation often called monoclonal gammopathy of undetermined significance (MGUS), which will increase myeloma threat. Half had been vaccinated, half unvaccinated.

Over two to 41 weeks of follow-up, the effectiveness of vaccination in stopping an infection diversified extensively. After two doses, it was 5.6% in myeloma sufferers, and 27.2% in folks with MGUS. This compares with 85% in most cancers survivors not on therapy.

Vaccine effectiveness began to say no about six months after sufferers’ second dose, the research discovered.

The myeloma affected person findings had been offered Sunday at a gathering of the American Society of Hematology in Atlanta. Research offered at conferences ought to be thought of preliminary till printed in a peer-reviewed journal.

Researchers stated the decrease effectiveness of vaccination in myeloma sufferers probably owes to each the illness itself and to its therapy. Both can weaken the immune system.

“We found that, compared to patients who hadn’t been treated in the last six months, the rate of breakthrough infections was 2.6%,” Munshi stated in a Dana-Farber information launch.

“For patients who were treated within the last 90 days, that number goes up to 4-5%,” he added. “And in patients treated with daratumumab [an immunotherapy agent], the number was 9%.”

More data

The American Cancer Society has extra on a number of myeloma.

SOURCE: Dana-Farber Cancer Institute, information launch, Dec. 11, 2021

The post COVID Vaccines Offer Only Some Protection for People With Myeloma appeared first on Healthy and Slim Life.

WEDNESDAY, Oct. 27, 2021 (HealthDay News) — Anti-vaxxers felt their suspicions confirmed when former U.S. Secretary of State Colin Powell died from COVID-19 problems in mid-October regardless of being absolutely vaccinated.

But Powell, 84, was being handled for blood most cancers on the time of his demise, and a brand new research reviews that the COVID vaccines are producing little to no safety for some most cancers sufferers.

Nearly 3 out of 5 blood most cancers sufferers didn’t mount an immune response towards COVID after receiving a full two-dose course of the Pfizer vaccine, based on medical trial outcomes from the United Kingdom.

People with stable tumors additionally had a much less sturdy response to COVID vaccination in contrast with wholesome of us, researchers added.

The new research “demonstrates to us that individuals with each stable tumors and in addition blood cancers don’t reply optimally to vaccines, and notably to COVID vaccine,” stated Dr. William Schaffner, medical director of the Bethesda, Md.-based National Foundation for Infectious Diseases. “They have demonstrated it with a sureness and a completeness that we did not have earlier than.”

Powell died whereas battling a number of myeloma, a blood most cancers that notably impacts the immune system. He had been scheduled to obtain a 3rd COVID vaccine booster shot, however died earlier than his appointment.

“Although we’re properly to attempt to get them to reply by giving them a 3rd dose of vaccine, our expectations should not be too excessive, and neither ought to the sufferers’ [expectations],” Schaffner stated.

For this trial, Dr. Sheeba Irshad, a senior medical lecturer from King’s College London, and colleagues administered the Pfizer vaccine to 159 folks, 128 of whom have been most cancers sufferers. They then tracked their immune response. The outcomes have been revealed Oct. 11 within the journal Cancer Cell.

The researchers discovered that solely 36% of blood most cancers sufferers achieved an immune response to COVID following full vaccination, in contrast with 78% of stable most cancers sufferers and 88% of the wholesome management individuals.

The first dose of vaccine did not work notably properly in stable most cancers sufferers, with solely 38% growing an immune response to COVID. But a second dose given at both 3 or 12 weeks boosted safety.

Cancers are inclined to wreak havoc with the physique’s immune system, notably cancers of the blood, Schaffner stated.

Blood cancers “continuously contain cells that work together with or are part of the immune system — lymphomas, for instance. The illness itself reduces the capability of the immune system to operate usually,” Schaffner stated.

The research factors out that older age — a recognized hyperlink to extreme COVID — takes a again seat to most cancers, stated one professional.

“A most cancers prognosis appears to trump age as a threat issue for a weaker immune response,” stated Dr. Julie Gralow, government vice chairman and chief medical officer of the American Society of Clinical Oncology.

The remedies used to remedy most cancers — chemotherapy, radiation remedy, immunotherapy — can also intervene with immune response, stated Dr. Betty Hamilton, interim director of the Cleveland Clinic Blood and Marrow Transplant Program.

“We have had the sense that sufferers who’re immunosuppressed or immunocompromised in a roundabout way have much less response to the vaccine,” Hamilton stated, citing most cancers sufferers in addition to sufferers present process organ transplant.

Still, most cancers sufferers ought to get the COVID vaccine and booster, Hamilton and Schaffner stated.

“We do nonetheless advocate vaccination for these sufferers as a result of we do consider that a bit of little bit of safety is best than none,” Hamilton stated.

Best wager is to quarantine

But their greatest wager to remain COVID-safe is to quarantine, and for the folks round them to get vaccinated and stick tight to public well being suggestions, the specialists stated.

“If you’re one among these folks, or one of many folks round these folks, it’s a must to watch out,” Schaffner stated. “Use the masks. Be very cautious with social distancing, and keep away from crowds. And actually the folks round them ought to be vaccinated.”

Hamilton agreed.

“It’s actually vital to counsel these sufferers that they nonetheless must be very cautious in public and to put on masks and wash their palms continuously,” Hamilton stated.

“My specialty is bone marrow transplant, and so our sufferers are extraordinarily immunosuppressed,” she stated. “Oftentimes after transplant they use these public well being measures anyway. Even with out COVID, they have been utilizing these strategies of avoiding crowded locations and carrying masks and washing their palms continuously and avoiding people who find themselves unwell.”

This menace to most cancers sufferers additional emphasizes the necessity for as many individuals in the neighborhood as potential to get vaccinated towards COVID, Hamilton and Schaffner added.

“If you allow this virus to flow into in the neighborhood, sometimes it’s going to sneak via the perimeter that we create round these folks. It can get in and infect one among these folks and make them gravely unwell,” Schaffner stated.

“You can consider everybody round Colin Powell with a military’s precision was going to be protected. Nobody needed to be the dreaded spreader who gave it to Colin Powell, but it surely acquired via to the Powell household anyway,” he continued. “That occurs when the virus remains to be on the market circulating in the neighborhood and hasn’t but been suppressed optimally.”

And it is not simply folks with most cancers who could be protected by herd immunity to COVID, Schaffner stated.

“There are many extra frail folks round us than we’re used to, as a result of medical science is such that individuals are dwelling older. They’re dwelling frailer. People with underlying critical sicknesses like cancers of varied varieties reside longer amongst us,” Schaffner stated. “We all share a duty to assist defend our frail brothers and sisters who reside amongst us.”

More data

The U.S. Centers for Disease Control and Prevention has extra on COVID-19 vaccines for immunocompromised sufferers.

SOURCES: William Schaffner, MD, medical director, National Foundation for Infectious Diseases, Bethesda, Md.; Julie Gralow, MD, government vice chairman and chief medical officer, American Society of Clinical Oncology; Betty Hamilton, MD, interim director, Cleveland Clinic Blood and Marrow Transplant Program; Cancer Cell, Oct. 11, 2021

The post Many Blood Cancer Patients Get Little Protection From COVID Vaccine appeared first on Healthy and Slim Life.